NIH please change your protocol: Ivermectin prevents & cures Covid19.
Dear Representative,
Covid19 vaccine(s) are on the horizon, but most of us will not have access to the vaccine for many months.
** There's something available NOW which can prevent, reduce severity of, and treat Covid19. It has been around for decades and has been approved by the FDA.
Ivermectin in prophylaxis and treatment of COVID19 could help to immediately alter the trajectory of this pandemic.
The Front Line Covid-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+.
https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-I-MASK-Protocol-v5-2020-11-28-ENGLISH.pdf
This protocol is centered around the use of Ivermectin, a well-known anti-parasite drug with recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
The FLCCC Alliance calls on national health authorities to immediately review medical evidence showing the efficacy of ivermectin for the prevention of COVID-19 and as an early outpatient treatment.
Please urge the CDC, the NIH and the WHO to establish new guidance on prescribing Ivermectin for COVID19.
Covid19 vaccine(s) are on the horizon, but most of us will not have access to the vaccine for many months.
** There's something available NOW which can prevent, reduce severity of, and treat Covid19. It has been around for decades and has been approved by the FDA.
Ivermectin in prophylaxis and treatment of COVID19 could help to immediately alter the trajectory of this pandemic.
The Front Line Covid-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+.
https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-I-MASK-Protocol-v5-2020-11-28-ENGLISH.pdf
This protocol is centered around the use of Ivermectin, a well-known anti-parasite drug with recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
The FLCCC Alliance calls on national health authorities to immediately review medical evidence showing the efficacy of ivermectin for the prevention of COVID-19 and as an early outpatient treatment.
Please urge the CDC, the NIH and the WHO to establish new guidance on prescribing Ivermectin for COVID19.
View Comments